Pharma Co. Clarus Hits Ch. 11 With Plan To Sell Sole Drug
By Rick Archer · September 6, 2022, 10:21 AM EDT
Drug company Clarus Therapeutics filed for Chapter 11 protection in Delaware bankruptcy court, saying it is over $54 million in debt and is seeking to auction off its sole asset, a...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login